electroCore, Inc. (ECOR) has a MoatMap StockRank of 75/100 based on Quality (32/100), Value (50/100), and Momentum (77/100) factor scores. The current signal is BUY. electroCore is a micro-cap medical device company specializing in vagus nerve stimulation. It is unprofitable, highly speculative, and lacks the established quality metrics and scale required for our concentrated fund.
electroCore, Inc. is a commercial-stage medical device company that develops and commercializes non-invasive vagus nerve stimulation therapies, primarily under the gammaCore brand. The company's competitive moat is its patented, non-invasive technology platform that offers a drug-free alternative for treating primary headaches and other autonomic nervous system disorders. electroCore operates as a pioneer and niche leader in the bioelectronic medicine sector.
| Price | $9.52 |
| Market Cap | $77M |
| P/E (Forward) | -18.07 |
| Price/Book | -14.20 |
| Return on Invested Capital | -182.7% |
| Gross Margin | 87.2% |
| Operating Margin | -55.5% |
| Revenue Growth | 42.6% |
| Free Cash Flow | $-870K |
electroCore, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).